Acompanhamento farmacoterapêutico em leucemia mieloide crônica : avaliação das intervenções farmacêutica

• Autor(a) principal: Silva, Ana Vládia Brasileiro de Araujo
• Data de Publicação: 2016
• Outros Autores: Rodrigues Neto, Edilson Martins, Girão Júnior, Francisco Josimar, Araujo, Priscila Mesquita Chaves, Viana, Eugenie Desirèe Rabelo Néri, Fonteles, Marta Maria de França
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Institucional da Universidade Federal do Ceará (UFC)
• Texto Completo: http://www.repositorio.ufc.br/handle/riufc/22811
• topic: Atenção Farmacêutica; Leucemia Mielogênica Crônica BCR-ABL Positiva; Toxicologia

Objectives: To monitor patients being treated with tyrosine kinase inhibitors, describing the problems related to drug during the follow-up. Methods: this work is a descriptive and prospective study, conducted during the pharmaceutical care to patients of chronic myeloid leukemia clinic of the Hospital Universitário Walter Cantídio in the Universidade Federal do Ceará, from September 2012 to August 2013. The pharmaceutical interventions were classified systematically and the statistical analyzes were performed using Epi Info v. 3.5.1 program. They were followed a total of 74 patients. Results: we identified 258 problems related to the drug and in return were held 267 pharmaceutical interventions. Conclusions: from the above we can see the importance of individual monitoring of patients through the practice of pharmaceutical care, performing guidelines regarding the treatment with tyrosine kinase inhibitors by monitoring drug therapy and providing information on major adverse reactions, thus ensuring a good adherence to treatment.